?冠(08606.HK)购LED产品独家代理权 涉4,800万元以发行CB支付
?冠控股(08606.HK)公布,公司间接全资附属?冠科技,同意向卖方大连绚铄科技收购LED产品独家代理销售权,代价为4,800万元,将透过发行可换股债券的方式支付,每股换股价为0.3元,较公司股份上交易日收价每股0.35元折让约14.29%。假设换股权按换股价悉数行使,1.6亿股新股将配发予卖方,占公司已发行股本约20%,及经扩大後已发行股本约16.67%。
完成後,买方将收购LED产品独家代理销售权15年,即对室内、室外工厂及其他场所LED照明设计和产品的全球独家代理销售和售後服务(台湾除外)拥有的权利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.